To understand stomach cancer, it is helpful to know the basic parts of the stomach. The stomach has different sections called the cardia, fundus, body, antrum, and pylorus. Cancer can start in any of these areas, but it is now more commonly seen near the upper part of the stomach where it joins the food pipe.

In the early stages, the cancer stays in the inner lining of the stomach. As the disease grows, it spreads deeper into the stomach wall and may reach nearby organs such as the liver, pancreas, colon, and spleen. In advanced stages, the cancer can also spread to nearby lymph nodes, which may allow it to move to other parts of the body.

Not all stomach cancers are the same. Understanding the specific type helps guide the most appropriate gastric cancer treatment strategy:

• Adenocarcinoma: The most prevalent type, accounting for the overwhelming majority of stomach cancer cases. It originates in the glandular cells that secrete mucus and digestive juices.
• Gastrointestinal Stromal Tumors (GISTs): These develop from the connective tissue cells of the stomach wall and often respond to targeted therapy rather than conventional chemotherapy.
• Carcinoid Tumors: These originate from hormone-producing cells in the stomach lining and tend to grow slowly compared to other types.
• Lymphoma: Though rare, the stomach can be the site of lymphoma a cancer of the lymphatic tissue  which requires a very different treatment approach from standard stomach cancer protocols.

Each subtype carries distinct biological characteristics, growth patterns, and responses to therapy, which is why accurate histological diagnosis is a cornerstone of planning effective gastric cancer treatment.

Gastric cancer does not develop overnight. It is typically the result of years of damage to the stomach's mucosal lining, which over time leads to DNA mutations in epithelial cells. These mutations disrupt normal cell regulation, leading to uncontrolled proliferation and eventually tumor formation.

The most well-established cause of gastric cancer is chronic infection with Helicobacter pylori (H. pylori), a bacterium that colonizes the stomach lining and triggers persistent inflammation. This ongoing inflammation damages the mucosal barrier, promotes genetic instability, and significantly elevates the risk of adenocarcinoma  particularly in the distal (lower) stomach. Other contributing factors include:

•       Chronic acid reflux (GERD), especially linked to cancers at the gastroesophageal junction
•       Regular consumption of salty, pickled, or smoked foods that contain carcinogenic nitrosamines
•       Chronic atrophic gastritis  long-term inflammation that causes loss of stomach gland cells
•       Cigarette smoking, which introduces carcinogens directly into the gastrointestinal tract
•       Hereditary conditions such as familial adenomatous polyposis (FAP), Lynch syndrome, and hereditary diffuse gastric cancer (HDGC)

Understanding these root causes is not merely academic  it informs prevention strategies and guides early screening in high-risk populations.

Certain individuals carry a statistically higher risk of developing gastric cancer. While having one or more risk factors does not mean cancer will develop, awareness empowers timely medical consultation and proactive screening. Key risk factors include:

•       Age above 60, as cancer incidence rises significantly in older adults
•       Male sex  men are approximately twice as likely to develop gastric cancer as women
•       Long-term smoking and tobacco use
•       Obesity, particularly associated with gastroesophageal junction cancers
•       A long-term diet high in salty, smoked, or preserved foods. 
•       Low intake of fresh fruits and vegetables, which are protective against many cancers
•       Presence of gastric polyps, particularly adenomatous polyps
•       Family history of stomach cancer or a known inherited genetic syndrome

At Kannappa Memorial Hospital, our oncology team offers personalized risk assessment consultations for individuals with one or more of these factors, helping to detect any precancerous changes well before a diagnosis of stomach cancer.

One of the greatest challenges with gastric cancer is that early-stage disease is often asymptomatic or presents with vague discomfort easily attributed to common digestive issues. This is why the majority of patients are diagnosed at an advanced stage.

• Early Symptoms: In the beginning, stomach cancer may cause symptoms like indigestion, heartburn, feeling full quickly after eating, stomach bloating, mild stomach pain, or loss of appetite. These symptoms are common in many people and are not always serious. But if they continue for a long time, it is important to see a doctor.
• Progressive Symptoms: As the cancer grows, the symptoms become more serious. A person may have constant stomach pain, weight loss without reason, nausea, vomiting, trouble swallowing, tiredness, and weakness. Sometimes there may also be blood in vomit or black-colored stools because of internal bleeding.
• Advanced Symptoms: In later stages, the cancer may spread to other parts of the body. This can cause yellowing of the eyes and skin, swelling in the stomach area because of fluid buildup, enlarged lymph nodes, and severe weakness. At this stage, treatment mainly helps control symptoms and improve the patient’s comfort and quality of life.

Accurate and timely diagnosis is the cornerstone of effective gastric cancer treatment. The diagnostic process typically begins with a thorough medical history review and physical examination, followed by a carefully planned sequence of investigations:

• Upper Gastrointestinal Endoscopy: This is the gold standard for detecting stomach cancer. A thin, flexible tube with a camera is passed through the mouth to visualize the stomach lining directly, allowing the physician to identify suspicious lesions.
• Biopsy: During endoscopy, tissue samples are taken from abnormal areas and examined under a microscope to confirm the presence of cancer cells and determine their subtype.
• CT Scan and PET Scan: These imaging studies assess the extent of the disease  whether cancer has spread to lymph nodes or distant organs and are essential for staging.
• Endoscopic Ultrasound (EUS): Advanced diagnostic procedure used to determine how far the tumor has spread into the stomach wall and to check if nearby lymph nodes are affected. 
• Blood Tests and Tumor Markers: Routine blood work assesses overall health and organ function, while specific markers can provide supplementary diagnostic information.
• Diagnostic Laparoscopy: In selected cases, a minimally invasive surgical procedure is performed to directly examine the abdominal cavity for signs of spread that may not be visible on imaging.

The multidisciplinary team at Kannappa Memorial Hospital coordinates all diagnostic steps efficiently under one roof, ensuring patients receive a complete and accurate picture of their condition before any treatment decisions are made.

Modern Gastric Cancer treatment includes personalized care plans, advanced therapies, surgery, chemotherapy, and multidisciplinary specialists working together to improve treatment outcomes, enhance recovery, manage symptoms effectively, and provide better quality of life for patients.

• Surgery: Surgery is the main treatment for gastric cancer when it is found early and can be removed. Depending on how far the cancer has spread, doctors may remove part of the stomach (partial gastrectomy) or the whole stomach (total gastrectomy). Nearby lymph nodes are also removed to reduce the chance of cancer spreading. For very early-stage cancers, a less invasive procedure called Endoscopic Submucosal Dissection (ESD) can remove the tumor without major surgery.
• Chemotherapy: Chemotherapy uses medicines to destroy cancer cells. It may be given before surgery to shrink the tumor or after surgery to reduce the risk of the cancer returning. In advanced cancer, chemotherapy helps slow cancer growth, relieve symptoms, and improve survival. Common medicines include 5-FU, oxaliplatin, and cisplatin.
• Radiation Therapy: Radiation therapy uses powerful high-energy beams to destroy cancer cells and help prevent the spread of cancer. Radiation may be used before surgery, after surgery, or to reduce symptoms such as pain, bleeding, or blockage in advanced cancer cases.
• Targeted Therapy: Targeted therapy works on specific proteins or markers found in cancer cells. For example, trastuzumab is used for HER2-positive gastric cancer and can improve treatment results. Other targeted medicines help stop cancer from growing by blocking blood supply to tumors.
• Immunotherapy: Immunotherapy works by helping the immune system recognize and attack cancer cells. Medicines such as pembrolizumab and nivolumab are used mainly in advanced gastric cancer. These treatments are especially helpful for patients with certain biomarkers like high PD-L1 or MSI-high tumors and have improved outcomes for many patients.

While no strategy can guarantee complete protection, adopting certain lifestyle practices significantly reduces the risk of developing stomach cancer. At Kannappa Memorial Hospital, our preventive oncology approach emphasizes:

•       Increasing daily intake of fresh fruits and vegetables rich in antioxidants and fiber
•       Reducing or eliminating consumption of smoked, pickled, salted, and preserved foods
•       Stopping smoking and staying away from secondhand smoke exposure. 
•       Maintaining a healthy body weight through balanced diet and regular physical activity
•       Undergoing regular endoscopic surveillance if you have chronic gastritis, gastric polyps, or a strong family history of stomach cancer

Preventive lifestyle changes play a key role in reducing the need for complex Gastric Cancer treatment later in life. 

The prognosis of Gastric Cancer mainly depends on the stage at which the disease is detected and treated.

• Early-stage cancer: Patients often have a higher survival rate with timely surgery and adjuvant therapies such as chemotherapy or radiation therapy.
• Locally advanced cancer: Treatment usually involves a combination of surgery, chemotherapy, radiation therapy, and targeted treatments for better disease control.
• Metastatic cancer: The primary goal of treatment is to relieve symptoms, slow disease progression, and improve the patient’s quality of life.

Detecting the disease at an early stage greatly improves the chances of successful treatment and recovery. Recent advances in Gastric Cancer treatment, including targeted therapy, immunotherapy, and improved surgical techniques, have contributed to better survival outcomes even in advanced stages of the disease.

Very good treatment, very happy, will recommend for my known persons for treatment, Ms Vijaya Lakshmi ( Ms Nazreen and Ms Hemachitra ) and entire Staffs and Sisters are very kind and friendly.

Gastric cancer is a serious but increasingly treatable condition when diagnosed early and managed with a comprehensive medical approach. Understanding its symptoms, risk factors, and diagnostic pathways is essential for timely intervention. Modern Gastric Cancer treatment has evolved significantly, combining surgery, chemotherapy, radiation, targeted therapy, and immunotherapy to improve survival outcomes and patient quality of life.

Hospitals like Kannappa Memorial Hospital play a crucial role in delivering advanced, patient-centered oncology care with a multidisciplinary approach. Early consultation, proper screening, and lifestyle modifications remain the strongest tools in reducing gastric cancer burden. With increasing awareness and medical advancements, the outlook for gastric cancer patients continues to improve, especially when treatment begins at an early stage.